Other

Dataset Information

0

Polyclonal expansion of functional tumor-reactive lymphocytes infiltrating glioblastoma for personalized cell therapy


ABSTRACT: Tumor-infiltrating lymphocyte (TIL)-therapy has received FDA approval for the treatment of advanced melanoma and shows potential for broader applications in solid tumors, including glioblastoma. In this study, tumor-reactive TILs (tr-TILs) are isolated and enriched for CD137 expression from cavitron ultrasonic aspirator (CUSA) emulsions of 161 adult patients diagnosed with diffuse gliomas. Tr-TILs are successfully expanded in 87 out of the 161 patients, reflecting an expansion rate of 54%. Notably, the presence of IDH1 mutation and the cumulative dose of steroids are identified as significant negative predictors of expansion efficacy. The expanded tr-TILs exhibit distinct phenotypic and molecular dysfunctional features yet show upregulated expression of progenitor/memory-like markers and polyclonal T-cell receptors. Importantly, these tr-TILs demonstrate specific antitumor reactivity against autologous tumor cells in both in vitro and in vivo xenograft models. These findings provide a compelling background for a personalized immunotherapeutic approach while tackling one of the most significant challenges in oncology.

ORGANISM(S): Homo sapiens

PROVIDER: GSE299789 | GEO | 2025/06/23

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-12-29 | E-MTAB-12910 | biostudies-arrayexpress
2023-08-01 | GSE229858 | GEO
2023-08-01 | GSE229860 | GEO
2024-09-13 | GSE261023 | GEO
2023-08-01 | GSE234352 | GEO
2024-01-31 | GSE244613 | GEO
2013-01-03 | E-GEOD-43260 | biostudies-arrayexpress
2022-12-31 | GSE216559 | GEO
2022-12-31 | GSE216229 | GEO
| EGAS00001006952 | EGA